中国生物制药(01177.HK)获执行董事谢炳增持349.6万股

Group 1 - The core point of the article is that Xie Bing, an executive director of China Biologic Products Holdings (01177.HK), has increased his shareholding in the company by purchasing 3.496 million shares at an average price of HKD 5.8749 per share, totaling approximately HKD 20.539 million [1] - Following this purchase, Xie Bing's total shareholding has risen to 1,692,270,241 shares, increasing his ownership percentage from 9.00% to 9.02% [1]